About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
Connect with HiRO at the 2026 AAD Annual Meeting
Heading to the 2026 AAD Annual Meeting? Connect with the HiRO Team in Denver The…
Article Date
March 13, 2026
This article is featured on another website.
Go to article
Related posts
Browse all articles
July 14, 2026
Chime Biologics Congratulates Polpharma Biologics on Global Licensing Agreement with Teva for Ocrelizumab Biosimilar Candidate
July 14, 2026
Chime Biologics Congratulates Polpharma Biologics on Global Licensing Agreement with Teva for Ocrelizumab Biosimilar Candidate
August 14, 2026
From Bioprocessing to the Digital Age: Chime Biologics at the Bioprocessing Summit 2026
August 14, 2026
From Bioprocessing to the Digital Age: Chime Biologics at the Bioprocessing Summit 2026